drug manufacturers
COVID-19 vaccine boosters could mean billions for drugmakers
For Pfizer and Moderna, the boosters could be more profitable than the original doses because they won’t come with the R&D costs
Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates
The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes
Samsung BioLogics loses USD 6 billion in stocks
Samsung BioLogics reported a 1.9 trillion won (USD 1.77 billion) net profit in 2015.
Humans may soon develop drugs from ants
Experiments with 20 ant species found antimicrobials on 12 of them, a team reported in the Royal Society Open Science journal.
1 of 1